Form 4 for LXEO Lexeo Therapeutics, Inc.
Accepted 2024-06-14 00:00:00 ET · period of report 2024-06-12 · accession 0000950170-24-073371 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-06-14 | 2024-06-12 | LXEO | Otero Jose Manuel | Chief Technical Off | A - Grant | $0.00 | +31.2K | 31.2K | New | $0 |
| DT | 2024-06-14 | 2024-06-12 | LXEO | Otero Jose Manuel | Chief Technical Off | A - Grant | $0.00 | +187.5K | 187.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-12 | A | A | 31,250 | $0.00 | 31,250 | D | — | — | (F1) The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on August 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-12 | A | A | 187,500 | $0.00 | 187,500 | D | $18.19 · — to 2034-06-11 | 187,500 Common Stock | (F2) 25% of the shares underlying the option shall vest on May 20, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service. |